statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Bitcoin

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Invesco QQQ Trust Series 1

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Cartesian Therapeutics Plummets On 'Watershed Moment' For CAR-T Drugs

Cartesian Therapeutics Plummets On 'Watershed Moment' For CAR-T Drugs...

What Makes Cartesian Therapeutics, Inc. a New Buy Stock

Cartesian Therapeutics, Inc. (NASDAQ: RNAC) could be a solid addition to your portfolio given its recent upgrade to a Zacks Rank #2 (Buy). This rating change essentially reflects an upward trend in...

Cartesian Therapeutics Announces New Employment Inducement Grants

Cartesian Therapeutics, Inc. (NASDAQ: RNAC) (the Company), a clinical-stage biotechnology company developing mRNA cell therapies for the treatment of autoimmune diseases, today announced the granting...

Cartesian Therapeutics to Present at the ASGCT 27th Annual Meeting

Cartesian Therapeutics, Inc. (NASDAQ:RNAC) (the Company), a clinical-stage biotechnology company pioneering mRNA cell therapy for autoimmune diseases, today announced that recently reported...

Cartesian Therapeutics (NASDAQ:RNAC) Sets New 1-Year Low at $13.19

Cartesian Therapeutics, Inc. (NASDAQ:RNAC - Get Free Report)'s stock price reached a new 52-week low on Friday . The stock traded as low as $13.19 and last traded at $14.69, with a volume of 14103...

Cartesian Therapeutics to Participate in the 23rd Annual Needham Virtual Healthcare Conference

Cartesian Therapeutics, Inc. (NASDAQ:RNAC) (the Company), a clinical-stage biotechnology company pioneering mRNA cell therapy for autoimmune diseases, today announced that its management expects to...

Cartesian Therapeutics (NASDAQ:RNAC) Shares Scheduled to Reverse Split on Friday, April 5th

Shares of Cartesian Therapeutics, Inc. (NASDAQ:RNAC - Free Report) are scheduled to reverse split on Friday, April 5th. The 1-30 reverse split was announced on Friday, April 5th. The number of shares...

Cartesian Therapeutics (NASDAQ:RNAC) Shares to Reverse Split on Friday, April 5th

Cartesian Therapeutics, Inc. (NASDAQ:RNAC - Free Report) shares are scheduled to reverse split on the morning of Friday, April 5th. The 1-30 reverse split was announced on Friday, April 5th. The...

Cartesian Therapeutics' Strategic Stock Reorganization Wins Approval

Cartesian Therapeutics (RNAC) has issued an update. Cartesian Therapeutics, Inc. has successfully navigated significant corporate actions, gaining...

Cartesian Therapeutics, Inc. operates as a clinical-stage biotechnology company. It provides mRNA cell therapies for the treatment of autoimmune diseases. It operates in research and development of cell therapy product candidates. The company is headquartered in Gaithersburg, MD.

Volume	54,688.00
52-Wk High	$41.87
52-Wk Low	$11.67

RNAC Selecta Biosciences Inc

About

Feed

News

Sentiment

Earnings

Fundamentals